| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.6 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | -0.028 | 0.6 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | 0.072 | 0.6 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.6 |